{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/380331512"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "avirin for patients with genotypes 2 and 3 hepatitis C, two relatively uncommon forms of the infection.Panellists also backed sofosbuvir's use in combination with ribavirin and pegylated interferon alfa as a treatment for the more prevalent genotype 1 form of hepatitis C, which accounts for around 70 per cent of all cases in the US, as well as patients with genotype 4.Sofosbuvir is the first compo" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pmlive.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/502677209"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/380331512"] } } }
